• Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) held the Meet Delic conference from November 6-7, 2021, in Las Vegas, Nevada
• The event drew over 2,500 attendees, becoming the largest psychedelic wellness and business conference in the world
• The event featured over 60 expert speakers and thought leaders, including former NBA champion Lamar Odom and comedian Duncan Trussell
• Organizers have announced new dates for Meet Delic 2022 in Las Vegas

In 2015, famed NBA basketball star Lamar Odom was hospitalized in Las Vegas following a near-death overdose, which resulted in multiple seizures, strokes, and a coma. He would go on to make a full recovery, subsequently crediting his healing to psychedelic treatment, meditation and breathwork. Odom appeared at Meet Delic, the premier psychedelic wellness event, on November 7 in Las Vegas, Nevada, to share his journey from addiction to healing and preview his documentary Reborn with the film’s director, Zappy Zapolin. More than 2,500 people attended the event that featured over 60 thought leaders, medical professionals and wellness advocates, and over 20 hours of programming. “We’re so honored Lamar shared his personal story of healing with all of us at Meet Delic,” said Jackee Stang, co-founder of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF). “He has shown tremendous courage facing his past traumas and addiction, and his openness to exploring psychedelic treatments is inspiring. We hope his story opens the hearts and minds of more people so we can truly address the growing mental health crisis we’re facing” (https://ibn.fm/F4PY4). The Meet Delic conference aimed to raise awareness of the science-backed benefits of psychedelics and business opportunities inherent to the sector, and to the mainstream and larger global community. The event featured dancers, music, 3D-mapping, visual artists, new technologies and research, thought-provoking presentations, in addition to one of the world’s largest psychedelic business expos. This year’s event also featured The New York Times best-selling author, Chris Ryan, Ph.D.; physician and technologist, Dr. Molly Maloof; Ekaterina Maliesvskaia, co-founder of COMPASS Pathways; and Alyson Charles, shaman and host of the Ceremony Circle podcast. The twenty hours of panels and keynote discussions held over the course of the two-day event encompassed an array of topics, including:

• “Why are Psychedelics Medicine?”
• “How Big Money is (Already) Playing Psychedelics”
• “PTSD Reset and Recovery”
• “Psychedelics & Addiction: An Intimate Discussion on Recovery in a Modern World”
• “Ketamine Clinics Today, Psilocybin and MDMA Therapy Tomorrow”

The Meet Delic conference provided pioneering insights across two distinct tracks, namely, business and overall wellness, as leaders from across the industry came together to discuss the ideas shaping the future of psychedelics. As Jackee Stang elaborated on Delic’s flagship event, “I designed Meet Delic to be diverse, thought provoking and entertaining. Because the best kind of learning happens when you are also having fun.” Meet Delic 2022 will be held on November 4 and 5, 2022, in Las Vegas, and tickets are on sale now at MeetDelic.com. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• Point-of-care-testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more
• It is set to disrupt the clinical chemistry field, promoting a shift to a more decentralized testing approach
• Avricore is taking part in this disruption through its POCT platform, HealthTab, found at select community pharmacies
• HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results

Point-of-care testing (“POCT”), experts say, is set to disrupt the clinical chemistry field, with further development in this area facilitating expanded delivery of healthcare to resource-poor environments, providing better tools for monitoring chronic diseases, and allowing for routine health monitoring for health-conscious individuals (https://ibn.fm/23YkL). This disruption is contributing to a gradual shift from the traditional, more centralized testing approach in laboratories to a more decentralized system anchored in mobile communications and miniaturized diagnostic instruments. And, as an Abbott article notes (https://ibn.fm/k2Nvh), this has brought with it several benefits. “POCT is more convenient compared with traditional laboratory testing and has been shown to increase patient satisfaction. As a monitoring or screening tool, it can be used to support health screenings in those at risk of cardiovascular disease (‘CVD’) and improve patient compliance with testing frequency. There is now overwhelming evidence that POCT can offer significant strengthening of diagnostic precision of clinicians in a wide variety of areas,” the article, published in the 19th issue of Health Europa Quarterly, reads. The article further observes that “POCT contributes to faster results for physicians, greater flexibility for physicians and patients, lower costs, improved medication adherence, and reduced antibiotics prescribing.” Thanks to the vision and efforts of Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a health diagnostics solutions provider, an ever-expanding population of consumers around Canada can now enjoy these benefits. Avricore’s flagship offering, HealthTab(TM), pairs point-of-care analyzers – manufactured by partners such as the above-mentioned article’s author, Abbott – with a secure, cloud-based network to create a robust turnkey POCT platform that has a consumer-facing interface and is domiciled in community pharmacies. The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and trained health care professionals. In a November 23 announcement, Avricore celebrated the signing of a distribution agreement with Abbott that expanded its platform’s capabilities to better support patients with vital information about their renal function (https://ibn.fm/rb5Wa). “Understanding renal function in patients at risk from or already living with chronic disease is critical,” said Avricore CEO Hector Bremner. “With i-STAT Alinity and its associated test for creatinine, healthcare professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.” The company has also made significant progress in taking its services closer to even more patients. Since signing a Master Agreement to pilot its HealthTab platform in select Shoppers Drug Mart pharmacies in Ontario earlier this year, Avricore has rolled out its platform in additional locations, with the most recent move being expansion into British Columbia. Avricore is guided by the vision to create the world’s largest testing network in community pharmacies. It seeks to make actionable health insights more accessible for everyone, including researchers and drug makers seeking de-identified patient data for their clinical studies. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• SRAX’s BIGtoken platform announced their merger with BritePool Inc on September 27th, with both entities officially completing their merger on December 2, 2021
• SRAX have simultaneously revealed that they will no longer consolidate BIGtoken’s financials within their financial results
• Post-merger, SRAX’s core operations will focus on investor intelligence SaaS platform, Sequire, which now boasts over 9 million followers and 250 corporate subscribers
• Sequire has forecast to report $16.5 million in 4Q21, an accomplishment which would mark the company’s 12th consecutive quarter of revenue growth

SRAX (NASDAQ: SRAX) a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has recently announced that it will no longer have to consolidate the financials of its former subsidiary, BIGtoken, Inc (https://ibn.fm/ULbBn). BIGtoken, a proprietary consumer insights platform founded and operated by SRAX, Inc, was created with the purpose of enabling the over 16.7 million consumers on their platform to both own and monetize their digital data in an efficient and transparent manner. In turn, the platform’s customers – which encompass some of the world’s largest corporations– can submit questionnaires and surveys to BIGtoken’s subscribers, receiving rapid and actionable consumer data to help them better understand and serve their chosen audiences (https://ibn.fm/jRSRH). On September 27, 2021, BIGtoken and BritePool, Inc, a leading identity verification company for advertisers and publishers, jointly announced that the companies had entered into a merger agreement, in an all-stock transaction (https://ibn.fm/KhJn8). Both companies formally announced the completion of their merger as of December 2, 2021, with the combined entities changing their corporate name to BIGtoken, Inc. In addition, the merged entity revealed that they had applied with FINRA to change its Over-The-Counter (“OTC”) trading symbol, with the new trading symbol to be announced upon FINRA’s approval. The merger also involved a management reshuffle, with David J. Moore, co-founder, and former CEO of BritePool, being appointed as the CEO of BIGtoken. Prior to founding BritePool, David Moore served as president of advertising giant, WPP Digital, and chairman of Xaxis, WPP’s digital arm. Moore commented in relation to the merger, “By combining the capabilities and talent of our two organizations, BIGtoken is now poised for accelerated growth as a leader to deliver superior targeted marketing results for advertisers today and in the evolving privacy-oriented future.” Following the spin-off of its BIGtoken subsidiary, SRAX’s core operations will be centred around Sequire, its investor intelligence SaaS platform which has grown to boasting over 9 million followers on their platform whilst simultaneously seeing their number of subscribers swell to 250 public companies, a dramatic increase relative to the 225 companies on their platform in the second quarter, and up from a mere 92 subscribers as of their Q3 2020 results. Sequire has witnessed the company’s growth trajectory rise from strength to strength, with the company recently announcing the launch of their new IR website builder, their SMS communication platform, and VIRA, an IR-powered chatbot. SRAX and Sequire have also sought to provide additional value-added services to its legions of subscribers and followers by hosting the recent flagship and in-person LD Micro Event, an event which attracted over 750 in-person attendees and 12,000 virtual attendees. During their recent quarterly earnings call, SRAX’s management raised their fiscal year 2021 guidance to $31.5 million, underpinned by a sharp increase in Sequire bookings, with the platform estimated to deliver total Q4 booked revenues of $16.5 million – further extending a run which has now seen Sequire report twelve consecutive quarters of revenue growth. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Alexandra Moxin will leverage her years of experience in product, business development and digital transformation to help expand and promote the company’s platform, lqwd.tech
• Ms. Moxin has previously worked in product marketing for Microsoft and is the founder and host of Advance Tech Podcast, one of the most popular podcasts in the emerging tech space
• Launched mid-November, LQwD’s platform is fully scalable and adaptive and designed to simplify users’ access to the Lightning Network, while also making it easier to send payments instantly and securely

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on the creation of an enterprise-grade infrastructure that drives Bitcoin adoption and a Lightning Network provider, expanded its management team with a reputable digital transformation expert to help advance, grow, and promote the company’s Lightning Network platform-as-a-service (PaaS) offering. Alexandra Moxin, bringing more than a decade of experience in product, business development and digital transformation, was hired as Vice President of Product, effective immediately, according to a December 7, 2021, press release (https://ibn.fm/1c5jX). “The addition of Alexandra to LQwD’s management team is both timely and exciting,” company Chairman and CEO Shone Anstey said. “She is well versed in digital transformation and will be an integral part of the Company’s growth strategy in the Lightning Network space.” Ms. Moxin also brings a deep understanding of emerging technologies, from artificial intelligence and machine learning to cryptocurrencies, event-driven systems, and their impact. She is the founder of Advance Tech Media, publishers of one of the most popular podcasts in the tech world, the Advance Tech Podcast, where she regularly interviews worldwide leaders, founders, and developers from the emerging tech space. The podcast is ranked in the global top 10 percent of podcasts across all categories and reached one million downloads in a little over a year. In addition, Ms. Moxin worked in product marketing for Microsoft, where she focused on growing engagement in Azure, DevOps and OSS developer communities. She also served as Canadian Ambassaor for Microsoft’s Azure Tech Communities. In her new role as VP of Product for LQwD, Ms. Moxin will leverage her impressive expertise to hep grow the company’s recently launched lqwd.tech, a platform designed to facilitate and simplify access to the Lightning Network, as well as allow users to more easily send payments instantly, securely and inexpensively anywhere in the world. LQwD’s platform was launched on November 17. Simultaneously, the company deployed a part of its own Bitcoin holdings to procure additional nodes and provide liquidity for the platform. Aiming to empower institutions, businesses, and investors working with the Lightning Network, lqwd.tech was designed to be scalable and adaptive to the fast-paced growth of the Network. The Lightning Network allows for millions of Bitcoin transactions in seconds. LQwD’s platform makes it possible for users to:

• Easily create and manage Lightning Network nodes
• Make transactions securely, privately, and almost instantly, using the Network
• Create channels on the Network with effective routing
• Request and manage liquidity more efficiently

The company believes that the Lightning Network will be a force of global change and the premier monetary exchange network of the future. The Network itself has attained several major milestones in 2021, indicating its growing popularity. Since January, the Network has grown by more than 200 percent, driven largely by El Salvador’s decision to adopt Bitcoin as legal tender. “We’re right in the thick of it, and we’re the only public company in the world focused on the Bitcoin Lightning Network. We’re going to continue to put our stamp on that position,” Anstey said recently, during the InvestorBrandNetwork’s The Bell2Bell Podcast where he discussed his company’s business model and proven track record in the cryptocurrency industry (https://nnw.fm/b0Ifv). (https://ibn.fm/YIDx1). (https://ccw.fm/acihp). For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Robert Rositano Jr.’s recent appearance on the popular Hellblazer Biz Podcast highlighted the growth of Friendable’s Fan Pass Live artist platform, and what it offers to both artists and fans
• The Rositano brothers have been business partners for over 30 years and have always been interested in the music industry, coming up with the Fan Pass concept early in the 2000s and building it to its current position in the music industry
• Friendable’s flagship product has seen exceptional growth since its release in July 2020; growing from only 16 signed artists to a current total of over 6,000
• More than just a streaming platform, Fan Pass is becoming a lifestyle, as artists use the platform to share their everyday lives and perform as well as earn, with additional features becoming available for both artists and fans

From humble beginnings in July 2020, with only 16 artists on the platform, the Fan Pass Live artist platform has proven it has what it takes, going into 2022 with over 6,000 artists and fans subscribing monthly. The rapid growth of the platform, along with its most recent updates and mobile app, as well as the road ahead, were the main topics discussed by mobile technology and marketing company Friendable (OTC: FDBL) CEO and Co-Founder Robert Rositano Jr. with Chris Gordon, the host of Hellblazer Biz Podcast (https://ibn.fm/sfNTV). For almost 30 years now, the Rositano brothers (Robert Jr. and Dean) have been working together as business partners, sharing a passion for the music industry that mostly stems from Dean’s time touring and performing, even as a teenager. In the early 2000s, the brothers worked with a major industry name to produce a new venture/revenue stream for independent artists. Together with the help of Herbie Herbert and his partner Bill Graham and their recording studio, the brothers would record artists and invite friends, family, and fans to go online and vote for their favorite groups, purchase merchandise, and more. This venture was what brought about the birth of the Fan Pass Live artist platform. Over the years, technological advancements have made the Rositano brothers’ idea from the early 2000s more conducive. Advanced hardware and mobile technology aside, Wi-Fi was a major driver of industry progress, given that wireless connections allow continuous consumption of content, music in particular, Rositano said. Both Gordon and Rositano underlined that one of the key advantages the Fan Pass platform primarily offers is more freedom and control to artists. “We were trying to elevate the careers of these indie artists by not only giving them exposure, but a way to earn, utilizing the internet,” Rositano said. “It’s really always been about entertainment, music, educating – whether it’s an artist or a fan – and trying to provide technology and services that allow them to do that and have freedom and control.” And this key concept is the cornerstone of the Fan Pass offering nowadays. The platform offers artists multiple ways to reach fans and earn revenue on their own terms. A great solution for independent artists who don’t want to sign with a record label, Fan Pass Live is more than just a streaming platform — it can be equated to a lifestyle, as artists can share their everyday lives there, Rositano said. “They can perform, they can earn. And earning comes in several forms on our website and our mobile apps. We create merchandise, we share revenue, dropship through them, they can sell tickets to a live performance, schedule the event, and our teams are there to help them design and promote,” the Friendable CEO explained. “There are several different things that we offer and many more to come, and it’s exciting to have artists and fans really embracing the platform as we really get on our feet and start expanding our services.” Gordon called Fan Pass a Fan App, which Rositano confirmed to be synonymous. Fans can be hindered geographically, unable to see artists in venues or on stage, but Fan Pass puts them in the front row for only $2.99 per month (after the free trial). With many subscription-based services, the parent company is the beneficiary – not with Fan Pass – up to 40% of the monthly subscription goes back into the pockets of the performers that the fans love and follow each day. With more artists looking to represent themselves or gain control of their music, Fan Pass’s freedom allows artists to earn revenue while doing what they love. The Rositano brothers want artists to succeed and one way to support them in attaining this goal is by organizing monthly contests on the Fan Pass platform, typically shared, and announced on the company’s Instagram feed. The contest for the month of December, titled “Enter to Win”, will reward participating artists who sell the most tickets to ticketed streaming events during the month. The prizes for this contest include a $500 cash prize for first, $250 cash prize for second, and $150 cash for third place. A $30 bonus will be up for grabs as well. Any artist who promotes three ticketed events on IG with the tag @fanpasslive can get the additional $30. All artists participating come out winners during the contest, keeping 100% of their ticket sales and guidance on how to set up these events from Fan Pass live experts. Fans can also keep a lookout for the new winter apparel line that will be coming out soon and be available in the platform’s store. Fan Pass is available for mobile download on Google Play and the Apple Store. “We are really pushing the boundary on the freedom for artists to control their music,” Rositano Jr. underlined during the Hellblazer Biz Podcast. “Stay tuned as we are in the final stages of finalizing independent music distribution services, play listing and other services that will truly elevate the game of all our indie artists’ ability to succeed.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Date: December 13 to 16 EBC will hold a massive online event with over 120 world-class speakers and four days of livestreamed programming. The European Blockchain Convention is a four-day online event with motivational keynotes, panel discussions, workshops, one-on-one meetings, and high-level networking opportunities. The European Blockchain Convention offers a great opportunity to meet over 2.500 blockchain entrepreneurs, investors, corporations, developers, and tech leaders. The convention, which will be conducted online from December 13 to 16, will include access to an AI-powered networking tool that will allow the 2,500 guests to meet virtually on one-on-one basis. This year’s event will feature over 120 speakers, including Algorand Foundation CEO Sean Lee; Dr. Saifedean Ammous, author of “The Bitcoin Standard”; Bitstamp managing director Jean-Baptiste Graftieaux; Bank of Israel deputy governor Mr. Andrew Abir; Bank Santander head of blockchain Coty de Monteverde; Circle chief strategy officer Dante Disparte; Distrikt co-founder Andra Georgescu; ConsenSys Health founder. Key Points

• Almost 100 speakers, including representatives from Distrikt, the European Commission, the Bundesbank, and the World Economic Forum
• Rabobank, Henkel, Ikea, Commerzbank, Gemini, and the European Commission are among the key speakers
• Speakers include representatives from the German Ministry of Finance, the Swiss National Bank, and the Republic of Ireland

Why Should It Be Attended? Never before in history has there been an event with so much high-quality blockchain content. The talks will cover topics such as institutional DeFi adoption, security tokenization, stablecoins, the rise of NFTs, decentralized social media, CBDCs, the new era of financial services, self-sovereign identity, sustainability, social innovation, gaming in the metaverse, why DAOs matter, blockchain scaling solutions, green bonds, and so on. The industry is sweltering. According to CB Insights, global venture capital investing into blockchain firms hit an all-time high of $6.5 billion in the third quarter of 2021, surpassing the previous quarter’s total of $5.2 billion. Global VC investing into blockchain reached $15 billion in the first nine months of 2021, up 384 percent from the full-year total of $3.1 billion in 2020. A series of expert keynotes, engaging panel discussions, and solution-based case studies will be featured on the Blockchain conference agenda. Legal sectors, retail, financial services, healthcare, insurance, energy, music, government, real estate, and other businesses are among those expected to be affected the most by this new technology. For more information, please visit https://ibn.fm/NZfqF.

Date: December 15-17, 2021 Venue: Moscone Center, San Francisco, California NCIA’s 7th Annual Cannabis Business Summit & Expo will be held in the Moscone Center in San Francisco, California, on December 15-17, 2021. Hosted by the National Cannabis Industry Association (“NCIA”), the largest and oldest national trade association advancing the interests of the legal cannabis industry, the three-day event showcases cannabis industry professionals and advocates Troy Datcher, Calvin Johnson, Jr., Rachael Rapinoe, Anna Symonds, and Marvin Washington as keynote speakers. Key Points:

• Leading a new generation of c-suite innovators, Chief Executive Officer Troy Datcher, together with Chief Visionary Officer Shawn “JAY-Z” Carter, helms a cannabis business for the post-prohibition era at The Parent Company. Combining best-in-class operations with leading voices in popular culture and social impact, The Parent Company focuses on building brands that will pave a new path forward for a legacy rooted in equity, access, and justice.
• Troy Datcher will share his personal story and enlighten guests on his endeavor to create an impact in the cannabis industry in a “fireside chat” with MARY Magazine founder, Adrian Farquharson, at 10AM on Thursday, December 16.
• The second keynote, entitled ‘Wellness in Action: Elite Athletes as Cannabis Advocates,’ moderated by entrepreneur Jim McAlpine, will feature professional athletes and cannabis advocates Calvin Johnson, Jr., Rachael Rapinoe, Anna Symonds, and Marvin Washington of Athletes for CARE.
• This panel will discuss a variety of issues, including the progression and acceptance of cannabis in sports, as well as how athletes may have a significant impact on cannabis policy, at 10AM on Friday, December 17.

Why is #CannaBizSummit a Can’t-Miss Event? NCIA’s 7th Annual Cannabis Business Summit & Expo is the industry’s most significant national B2B trade exhibition, and the only event that brings together an exclusive lineup of education, exhibitors, and experiences under one roof. Over 125 speakers, more than 80 educational sessions, and hundreds of exhibitors will be featured at #CannaBizSummit 2021. Furthermore, at mixers and happy hours, event guests from throughout the country, including licensed retailers, cultivators, manufacturers, and consumer enthusiasts, will have the opportunity to make meaningful connections with fellow cannabis industry professionals. In addition, this year’s #CannaBizSummit venue was chosen for its historical relevance in the cannabis industry. San Francisco is both the gateway to the Emerald Triangle, the country’s largest cannabis-producing region, and the epicenter of the reform movement. For more information, please visit https://ibn.fm/ZUMXO

• PlantX is celebrating the expansion of its e-commerce platform to the United Kingdom
• The platform will offer a wide array of plant-based products, indoor plants, and educational resources
• The UK is the leading market for plant-based alternatives in Europe and has in the recent past witnessed changes that align perfectly with PlantX’s recent move
• The launch of the site fulfills the company’s mission and is a step in the right direction for the PlantX

In line with its mission of bringing more plant-based options to as many people as possible, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has announced the expansion of its e-commerce platform to the United Kingdom (“UK”). Set to be launched under the domain www.PlantX.uk, the new platform will offer customers a similar experience as PlantX’s customers in Canada and the United States have become accustomed to (https://ibn.fm/o5a3e). In addition to complementing Bloomboxclub UK, PlantX’s UK-based subsidiary that sells and delivers indoor plants across the United Kingdom and Germany via an online shop and subscription service, the new UK site will feature a wide array of plant-based goods, an assortment of educational resources such as blogs and recipes, and an extensive selection of indoor plants. “PlantX plans to introduce a wide selection of novel brands and products for the growing plant-based community in the United Kingdom,” commented company COO Julia Frank. “By offering consumers access to products that are new to the UK market, PlantX hopes to secure a competitive advantage in the dynamic plant-based retail ecosystem in the UK throughout and beyond the upcoming holiday season.” The timely launch dovetails with emerging trends in the UK’s plant-based space. According to a study conducted by the London School of Hygiene & Tropical Medicine (“LSHTM”) in collaboration with the University of Oxford, the proportion of UK people who reported eating and eating plant-based alternative foods nearly doubled between 2008-2011 and 2017-2019 from 6.7% to 13.1% (https://ibn.fm/Hq7Na). “The researchers say their study suggests that alternative plant-based foods are likely to play an important role in dietary change away from meat and dairy, and take a considerable place in UK diets,” reads a summary of the report. The LSHTM study is consistent with findings from separate research from the University of Oxford. According to this research, the daily meat consumption in the UK decreased by 17% between 2008/2009 and 2018/2019 (https://ibn.fm/MUP5g). Relatedly, a Mintel Research report established that the proportion of people who have limited or reduced their meat consumption increased from 28% in 2017 to 39% in 2019. Put together, these statistics have contributed to the UK’s status as the largest market for plant-based alternatives in Europe. Here, sales of meat-free foods increased by 40% from £582 million (US$771 million) in 2014 to an estimated £816 million (US$1.081 billion) in 2019. Mintel projects that this figure will grow further to more than £1.1 billion (US$1.458 billion) by 2024 (https://ibn.fm/NUkm4). In this regard, the new e-commerce site enables PlantX to tap into the UK’s appetite for plant-based alternatives and, through educational resources, possibly enhance the population’s knowledge of plant-based products even further. On his part, PlantX Founder, Sean Dollinger, noted that accessing the vast and flourishing UK market is a critical part of the company’s business plan, further underscoring that PlantX sees the launch as another step in the right direction. “Introducing new plant-based options to additional growing market segments is a recipe for success,” said PlantX CEO Lorne Rapkin. “Having our e-commerce site operational in the UK is the next evolutionary step on our way to expanding across the globe, and we’re excited to serve this market segment.” Notably, PlantX has partnered with one of the leading fulfillment companies in the UK, Access Fulfillment, to establish an effective supply chain infrastructure. With more than 20,000 square feet of warehouse space complete with refrigeration capabilities, Access’s facilities will ensure the centralized storage and distribution of PlantX’s plant-based products across the UK. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• MINDCURE President and CEO Kelsey Ramsden will participate in, and has already attended multiple industry conferences throughout December
• Participation in #CanndoraConnect: Women in Psychedelics Conference focused on exploring job opportunities in psychedelics
• Company remains focused on promoting healing and improving mental health via digital therapeutics technology and psychedelic compounds research
• Company reports that 971 million people worldwide suffer from a mental disorder. As of 2019, MINDCURE calculates that 12,472 registered mental health facilities treatment facilities could benefit from the company’s proprietary digital therapeutics technology, iSTRYM
• The global digital therapeutics market is valued at $3.4 billion and is projected to reach $13.1 billion by 2026, primarily driven by the growing need for control over healthcare costs and the rising focus on preventative health opportunities

Life sciences company Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) a leader in advanced proprietary technology and research for psychedelics, is rounding out 2021 by participating in the Life Sciences Investor Forum, a virtual investor conference that provides a fully interactive forum where publicly-traded companies can meet and present directly to investors. President and CEO of MINDCURE, Kelsey Ramsden, will be presenting virtually during the Life Sciences Investor Forum – which will be available archived on the conference’s website after the event has concluded (https://ibn.fm/q34CM). The virtual forum will take place on December 16, 2021, with MINDCURE presenting at 11:30 AM EST. Ms. Ramsden has already presented at three other industry events thus far in December – including the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, the Psychedelics Now Virtual Conference on December 8, and #CanndoraConnect: Women in Psychedelics Conference on December 8. The presentation at H.C. Wainwright will be available to the public for 90 days following the conference, on MINDCURE’s investor relations website, and requires registration (https://ibn.fm/dzpnW). At the Psychedelics Now Virtual Conference, Ms. Ramsden participated in the “Road to Monetization” webcast panel, which is currently available online (https://ibn.fm/WEZe4). Registration is required to view the panel. Ms. Ramsden’s participation in #CanndoraConnect: Women in Psychedelics Conference focused on exploring job opportunities in psychedelics. MINDCURE expects growing job opportunities in the industry, as the psychedelics sector is expanding. Research cited by the company indicates that the global functional mushroom market will reach a value of $37 billion by 2025, up from the $23 billion value it held in 2019 (https://ibn.fm/Cx5M8). The company’s focus on developing psychedelic compounds to scale science-backed and evidentiary-based mental health therapy worldwide via digital therapeutics were among the topics discussed at December’s events. Part of MINDCURE’s philosophy is about investing in the moment, and MINDCURE’s moment focuses on the psychedelic and digital therapeutics markets. The company reports that 971 million people worldwide suffer from a mental disorder. As of 2019, MINDCURE calculates that 12,472 registered mental health treatment facilities could benefit from the company’s proprietary digital therapeutics technology, iSTRYM. The minimum viable product version of iSTRYM was so far made available to 20 ketamine clinics in nine different states in the U.S. and three Canadian provinces, and the company plans to launch full commercial deployment in Q1 or Q2 next year and to enter the European market later in 2022. As member of the Digital Therapeutics Alliance with a dedicated product that is already being used successfully, MINDCURE has a prominent position in the global digital therapeutics market. This market is currently valued at $3.4 billion, according to 2021 figures. The market is projected to reach $13.1 billion by 2026, growing at a CAGR of 31.4%. This growth is being facilitated by the need to control healthcare costs and the rising focus on preventative healthcare options (https://ibn.fm/mE4wv). For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

• Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022
• The programs are designed to explore the ability of the company’s patented DehydraTECH(TM) to improve drug delivery processes for multiple indications
• Research will continue into the use of DehydraTECH-CBD for high blood pressure, as well as the technology’s potential for oral nicotine delivery

Diabetes, rheumatoid disease, Alzheimer’s Disease, and estrogen delivery, are some of the multiple indications that drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) is planning to target with its research and development programs next year. The markets targeted provide multiple opportunities for success and are now expected to reach an overall estimated value of more than $160 billion annually, worldwide over the next few years. The company will conduct pharmacokinetic and efficacy modelling studies to determine if its patented DehydraTECH(TM) technology can be used successfully to improve delivery of drugs or active pharmaceutical ingredients in these sectors, and to determine if there are specific commercial benefits to continue pursuing these markets. The largest sector targeted by the company is currently the diabetes therapeutics market, expected to reach $77.9 billion worldwide by 2024 (https://ibn.fm/PAFA0). With diabetes being the seventh largest cause of death in the United States, the market has the potential to generate impressive growth opportunities for the company. Lexaria’s R&D program for this indication, titled DIAB-A22-1 and likely to be launched in November 2022, will explore the impact of cannabidiol (“CBD”) delivered through the company’s proprietary DehydraTECH technology. Another major target market the company is the rheumatoid arthritis therapeutics sector, expected to reach a value of over $30 billion per year by 2025 (https://ibn.fm/pYzqd). There are currently over 100 rheumatic diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia. The company’s RHEUM-A22-1 efficacy study, likely to be launched in October 2022, will look into how DehydraTECH-CBD can potentially affect the treatment of rheumatoid arthritis, given CBD’s efficacy to reduce inflammation. The program DEM-A22-1, likely to begin in July 2022, will assess the use of DehydraTECH-delivered CBD, both paired with nicotine and without it, for the potential treatment of dementia. The dementia therapeutics market is estimated to reach $19.6 billion by 2026 and there are currently about 55 million people affected by dementia worldwide, with approximately 78 million more expected to face some form of dementia by 2030 (https://ibn.fm/aQpsi). The most common form of dementia is Alzheimer’s disease, accounting for roughly 60 percent of all cases. Another program targeting a major market is HOR-A22-1, a pharmacokinetic study that will try to determine if DehydraTECH can be used to enhance and improve the delivery characteristics of estrogen. Amid growing awareness of post-menopausal issues women face, and an increase in the prevalence of menopausal disorder, the hormone replacement market is anticipated to grow exponentially and reach $46.5 billion by 2027 (https://ibn.fm/8trBY). Lexaria Bioscience’s estrogen delivery study is tentatively scheduled to being in April 2022. In addition to the new R&D programs, Lexaria will continue the programs launched previously to explore the potential impact of DehydraTECH-delivered CBD on hypertension and heart disease, as well as the technology’s use for oral nicotine delivery as a potential alternative to smoking. Heart disease and smoking are the first and third, respectively, causes of death in the United States. With all the programs for 2022 fully funded due to the $15 million raised by the company this year, Lexaria is going into the new year with a busy roster of R&D programs. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX